Articles
Page 58 of 82
-
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P66
-
Specific ocular changes in TTR Met30-FAP after liver transplantation
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P64 -
Retinal and choroidal vascular abnormalities in TTR-FAP
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P61 -
Axon reflex-mediated vasodilation is reduced in proportion to disease severity in familial amyloid polyneuropathy
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P57 -
Identification of a new variant of TTR involved in familial amyloid cardiomyopathy (FAC) in Brazil: from the patient to the protein
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P55 -
Spotting senile systemic amyloidosis: why we miss it
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P51 -
Usefulness of 99mTc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P49 -
Quantitative comparison between amyloid deposition detected by 99mTc-diphosphonate imaging and myocardial deformation evaluated by strain echocardiography in transthyretin related cardiac amyloidosis
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P47 -
Coexistence of degenerative aortic stenosis and wild type transthyretin-related cardiac amyloidosis: a potentially dangerous association that can be non-invasively identified
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P45 -
Comparison of MIBG and Diphosphonate scintigraphy in cardiac involvement of aTTR-FAP
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P43 -
Disphosphonates cardiac uptake in familial amyloid neuropathy: Comparison between DPD and HMDP
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P41 -
Characterization of conformation-specific, human-derived monoclonal antibodies against TTR aggregates with potential for diagnostic and therapeutic use
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P39 -
What to do when the neuropathy worsens after successful heart and liver transplantation in a Glu89Lys Transthyretin Amyloidosis?
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P37 -
Genotypic and phenotypic presentation of Glu89Gln mutation in Turkey
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P33 -
Neurophysiological pitfalls in TTR-FAP Val30Met
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P31 -
Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P29 -
Psychopathological dimensions in familial amyloid polyneuropathy patients
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O27 -
Teachings from the French database of TTR familial amyloidotic polyneuropathy (TTR-FAP): large genetic and phenotypic heterogeneity, usefulness of TTR gene testing.
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P27 -
Familial Amyloid Polyneuropathy treatment with Tafamidis – evaluation of one- and two-year treatment in Porto, Portugal
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O25 -
Transthyretin-related Familial Amyloid Polyneuropathy (TTR-FAP) caused by a very rare, de novo mutation in a Polish patient.
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P25 -
Diflunisal therapy for cardiac ATTR amyloidosis: a longitudinal, prospective, single centre study
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O23 -
Patient experience with hereditary and senile systemic amyloidoses: a survey from the Amyloidosis Research Consortium
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P22 -
Heart transplantation in hereditary ATTR amyloidosis
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I22 -
Phase 2, open-label extension (OLE) study of revusiran, an investigational RNAi therapeutic for the treatment of patients with transthyretin cardiac amyloidosis
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O21 -
FAP in India: a first genetically proven case
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P20 -
Guidelines for genetic counselling in ATTR amyloidosis
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I20 -
Ocular manifestations of transthyretin-related familial amyloid polyneuropathy
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O19 -
Does the course of Val122Ile differ from SSA, or is selection bias a factor?
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P18 -
Cardiologic Phenotypes and Natural History of FAC
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I18 -
Familial amyloidotic polyneuropathy associated with the transthyretin CYS 114 gene in a Russian pair of monozygotic twins.
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P16 -
New tools to diagnose and follow FAC patients: biomarkers
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I16 -
Quantitative MR-neurographic parameters can determine and specify nerve injury in amyloid related polyneuropathy
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O14 -
Emerging CNS involvement in FAP-TTR long survival patients
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I14 -
Neurophysiological pitfalls in TTR-FAP Val30Met
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O12 -
Early intervention with tafamidis provides long-term benefit in delaying neurological progression in patients with transthyretin familial amyloid polyneuropathy
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P12 -
Analysis of disease progression in patients with transthyretin cardiac amyloidosis
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O10 -
TUDCA as an autophagic modulator of ATTR V30M Amyloidosis
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P10 -
ATTR-FAP: liver transplantation vs oral medication, how and when
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I8 -
A phase 3 clinical trial with ISIS-TTRRx, a 2nd-generation antisense oligonucleotide targeting transthyretin (TTR), for the treatment of TTR amyloid cardiomyopathy
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P8 -
DISCOVERY: a study examining the prevalence of transthyretin mutations in subjects suspected of having cardiac amyloidosis
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O8 -
TTR-FAP: liver transplant vs oral medication. How and when
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I6 -
Monitoring safety and effectiveness of Tafamidis in transthyretin amyloidosis in Italy: a 3-year longitudinal multicenter study in a non-endemic area
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P6 -
Familial amyloidotic polyneuropathy in Crete, Greece
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O6 -
When to decide to enroll a TTR-FAP patient in a Clinical Trial?
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I4 -
Positive real-world effectiveness of tafamidis for delaying disease progression in transthyretin familial amyloid polyneuropathy
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P4 -
The hidden story behind gender differences in familial amyloid polyneuropathy (FAP) ATTRV30M
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O4 -
Neuropathic phenotypes and natural history of FAP
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):I2 -
Diflunisal compassive use in transthyretin familial amyloidotic polyneuropathy (TTR-FAP): report of the first Spanish experience
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):P2 -
Epidemiology of Familial Amyloid Polyneuropathy in Bulgaria
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O2 -
TTR-FAP: a single-center experience in Sicily, an Italian endemic area
Citation: Orphanet Journal of Rare Diseases 2015 10(Suppl 1):O1
Follow
- ISSN: 1750-1172 (electronic)